Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Hartley

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
International Journal of Pharmaceutics|April 19, 2019
Development and pharmacokinetics of a combination vaginal ring for sustained release of dapivirine and the protein microbicide 5P12-RANTESJohn W McBride, R Karl Malcolm, Nicola Dias, et al.
Protein Engineering, Design & Selection : PEDS|April 27, 2017
Dual display: phage selection driven by co-engagement of two targets by two different antibody fragmentsSéverine Fagète, Ledicia Botas-Perez, Irène Rossito-Borlat, et al.
The Journal of Infectious Diseases|April 1, 2009
Topically applied recombinant chemokine analogues fully protect macaques from vaginal simian-human immunodeficiency virus challengeRonald S Veazey, Binhua Ling, Linda C Green, et al.
Frontiers in Immunology|May 2, 2017
Anti-Apolipoprotein A-1 IgG Predict All-Cause Mortality and Are Associated with Fc Receptor-Like 3 PolymorphismsPanagiotis Antiochos, Pedro Marques-Vidal, Julien Virzi, et al.
Nature Communications|August 18, 2025
Noncanonical roles of chemokine regions in CCR9 activation revealed by structural modeling and mutational mappingInês De Magalhaes Pinheiro, John R D Dawson, Nicolas Calo, et al.
Journal of Virology|June 29, 2004
PSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypesTatsuyoshi Kawamura, Shannon E Bruse, Awet Abraha, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 28, 2017
Impact of CD14 Polymorphisms on Anti-Apolipoprotein A-1 IgG-Related Coronary Artery Disease Prediction in the General PopulationPanagiotis Antiochos, Pedro Marques-Vidal, Julien Virzi, et al.
Thrombosis and Haemostasis|July 8, 2016
Association between anti-apolipoprotein A-1 antibodies and cardiovascular disease in the general population. Results from the CoLaus studyPanagiotis Antiochos, Pedro Marques-Vidal, Julien Virzi, et al.
Journal of Cardiopulmonary Rehabilitation|December 17, 2004
COPD results in a reduction in UCP3 long mRNA and UCP3 protein content in types I and IIa skeletal muscle fibersAaron P Russell, Emmanuel Somm, Richard Debigaré, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2008
Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicideHubert Gaertner, Fabrice Cerini, Jean-Michel Escola, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
International Journal of Pharmaceutics|April 19, 2019
Development and pharmacokinetics of a combination vaginal ring for sustained release of dapivirine and the protein microbicide 5P12-RANTESJohn W McBride, R Karl Malcolm, Nicola Dias, et al.
Protein Engineering, Design & Selection : PEDS|April 27, 2017
Dual display: phage selection driven by co-engagement of two targets by two different antibody fragmentsSéverine Fagète, Ledicia Botas-Perez, Irène Rossito-Borlat, et al.
The Journal of Infectious Diseases|April 1, 2009
Topically applied recombinant chemokine analogues fully protect macaques from vaginal simian-human immunodeficiency virus challengeRonald S Veazey, Binhua Ling, Linda C Green, et al.
Frontiers in Immunology|May 2, 2017
Anti-Apolipoprotein A-1 IgG Predict All-Cause Mortality and Are Associated with Fc Receptor-Like 3 PolymorphismsPanagiotis Antiochos, Pedro Marques-Vidal, Julien Virzi, et al.
Nature Communications|August 18, 2025
Noncanonical roles of chemokine regions in CCR9 activation revealed by structural modeling and mutational mappingInês De Magalhaes Pinheiro, John R D Dawson, Nicolas Calo, et al.
Journal of Virology|June 29, 2004
PSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypesTatsuyoshi Kawamura, Shannon E Bruse, Awet Abraha, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 28, 2017
Impact of CD14 Polymorphisms on Anti-Apolipoprotein A-1 IgG-Related Coronary Artery Disease Prediction in the General PopulationPanagiotis Antiochos, Pedro Marques-Vidal, Julien Virzi, et al.
Thrombosis and Haemostasis|July 8, 2016
Association between anti-apolipoprotein A-1 antibodies and cardiovascular disease in the general population. Results from the CoLaus studyPanagiotis Antiochos, Pedro Marques-Vidal, Julien Virzi, et al.
Journal of Cardiopulmonary Rehabilitation|December 17, 2004
COPD results in a reduction in UCP3 long mRNA and UCP3 protein content in types I and IIa skeletal muscle fibersAaron P Russell, Emmanuel Somm, Richard Debigaré, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2008
Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicideHubert Gaertner, Fabrice Cerini, Jean-Michel Escola, et al.
Pageof 9